CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)

Coronary Artery Disease Clinical Trial

— COACT  

Official title:

CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01239914
• Other study ID #: COACT
• Status: Completed
• Start date: January 2005
• Est. completion date: December 2019

Study information

• Verified date: September 2022
• Source: The Catholic University of Korea
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

COACT registry is a multicenter registry of consecutive patients undergoing coronary stent implantation at 8 centers in the Catholic University of Korea to evaluate the real world management of patients with coronary artery disease and to assess their in-hospital, medium and long-term outcomes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 11719
• Est. completion date: December 2019
• Est. primary completion date: December 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all consecutive patients who underwent percutaneous coronary intervention

• written informed consent for the DNA and serum databank

Exclusion Criteria:

• patients who did not agreed to participate

Related Conditions & MeSH terms

• Biomarker
• Cholesterol
• Coronary Artery Disease
• Coronary Disease
• Drug Eluting Stent
• Myocardial Ischemia
• Polymorphism

Locations

Country	Name	City	State
Korea, Republic of	Bucheon St.Mary Hospital	Bucheon	Gyeonggido
Korea, Republic of	Daejeon St.Mary's Hospital	Daejeon
Korea, Republic of	Incheon St.Mary's Hospital	Incheon
Korea, Republic of	Seoul St.Mary's Hospital	Seoul
Korea, Republic of	St.Paul's Hospital	Seoul
Korea, Republic of	Yeouido St.Mary Hospital	Seoul
Korea, Republic of	St.Vincent's Hospital	Suwon	Gyeonggido
Korea, Republic of	Uijeongbu St.Mary's Hospital	Uijeongbu	Gyeonggido

Sponsors (8)

Lead Sponsor	Collaborator
The Catholic University of Korea	Bucheon St. Mary's Hospital, Daejeon St. Mary's hospital, Incheon St.Mary's Hospital, Saint Vincent's Hospital, Korea, Seoul St. Mary's Hospital, St.Paul's Hospital, Korea, Yeouido St. Mary's Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	All causes mortality		6month, each year
Primary	Cardiac death		6 month, each year
Primary	Myocardial infarction		6 month, each year
Primary	target lesion revascularization		6 month, each year
Primary	target vessel revascularization		6 month, each year
Secondary	non target vessel revascularization		6 month, each year
Secondary	Stent thrombosis		6 month, each year
Secondary	Serum databank for evaluation of biomarkers outcomes		6 month, each year
Secondary	Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes		6 month, each year